Cholecystokinin-8S-induced intracellular calcium signaling in acutely isolated periaqueductal gray neurons of the rat

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 2, 2007, Pages 297-302

  Yang, Yu Mi ^a,b   Chung, Jun Mo ^b   Rhim, Hyewhon ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Ca 2+ channel; Cholecystokinin (CCK)2 receptor; Depolarization; Fura 2; Patch clamp recording; Periaqueductal gray

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CALCIUM; CALCIUM CHANNEL; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE; FURA 2; POTASSIUM CHANNEL; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ISOLATION; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DEPOLARIZATION; MEMBRANE CURRENT; NERVE CELL; NERVE CELL STIMULATION; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PERIAQUEDUCTAL GRAY MATTER; RAT;

ANIMALS; BENZODIAZEPINONES; CALCIUM SIGNALING; CALCIUM-TRANSPORTING ATPASES; CELLS, CULTURED; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; PERIAQUEDUCTAL GRAY; PHENYLUREA COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; SINCALIDE; THAPSIGARGIN;

EID: 33846950389     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.297     Document Type: Article

References (36)

1. Bandler R., Shipley M. T., Trends Neurosci., 17, 379-389 (1994).
2. Carrive P., Bandler R., Dampney R. A., Brain Res., 460, 339-345 (1988).
3. Basbaum A. I., Fields H. L., Annu. Rev. Neurosci., 7, 309-338 (1984).
4. Ossipov M. H., Lai J., Malan T. P., Jr., Porreca F., Ann. N.Y. Acad. Sci., 909, 12-24 (2000).
5. Behbehani M. M., Prog. Neurobiol., 46, 575-605 (1995).
6. Fanselow M. S., "The Midbrain Periaqueductal Gray Matter: Functional, Anatomical, and Neurochemical Organization," ed. by Depaulis A., Bandler R., Plenum Press, New York, 1991, pp. 151-174.
7. Benedetti F., News Physiol. Sci., 12, 263-268 (1997).
8. Noble F., Roques B. P., Neuropeptides, 36, 157-170 (2002).
9. Noble F., Wank S. A., Crawley J. N., Bradwejn J., Seroogy K. B., Hamon M., Roques B. P., Pharmacol. Rev., 51, 745-781 (1999).
10. De Belleroche J., Bandopadhyay R., King A., Malcolm A. D., O'Brien K., Premi B. P., Rashid A., Neuropeptides, 15, 201-212 (1990).
11. Liu H., Chandler S., Beitz A. J., Shipley M. T., Behbehani M. M., Brain Res., 642, 83-94 (1994).
12. Li Y., Han J. S., Brain Res., 480, 105-110 (1989).
13. Watkins L. R., Kinscheck I. B., Mayer D. J., Science, 224, 395-396 (1984).
14. Watkins L. R., Kinscheck I. B., Mayer D. J., Brain Res., 327, 169-180 (1985).
15. Tortorici V., Nogueira L., Salas R., Vanegas H., Pain, 102, 9-16 (2003).
16. Netto C. F., Guimaraes F. S., Neuropsychopharmacology, 29, 101-107 (2004).
17. Kopin A. S., Lee Y. M., McBride E. W., Miller L. J., Lu M., Lin H. Y., Kolakowski L. F., Jr., Beinborn M., Proc. Natl. Acad. Sci. U.S.A., 89, 3605-3609 (1992).
18. Wank S. A., Am. J. Physiol., 269, G628-G646 (1995).
19. Williams J. A., Sans M. D., Tashiro M., Schafer C., Bragado M. J., Dabrowski A., Pharmacol. Toxicol., 91, 297-303 (2002).
20. Daulhac L., Kowalski-Chauvel A., Pradayrol L., Vaysse N., Seva C., Biochem. J., 325, 383-389 (1997).
21. Seva C., Scemama J. L., Pradayrol L., Sarfati P. D., Vaysse N., Regul. Pept., 52, 31-38 (1994).
22. Jagerschmidt A., Guillaume N., Goudreau N., Maigret B., Roques B. P., Mol. Pharmacol., 48, 783-789 (1995).
23. Dickenson J. M., Hill S. J., Eur. J. Pharmacol., 302, 141-151 (1996).
24. Wang H. L., Br. J. Pharmacol., 121, 310-316 (1997).
25. Yang Y. M., Chung J. M., Rhim H., Life Sci., 79, 1702-1711 (2006).
26. Hahm E. T., Lee J. J., Min B. I., Cho Y. W., Neurosci. Res., 50, 343-354 (2004).
27. Clapham D. E., Nature (London), 375, 634-635 (1995).
28. Miller R. J., Science, 235, 46-52 (1987).
29. Herness S., Zhao F. L., Lu S. G., Kaya N., Shen T., J. Neurosci., 22, 10018-10029 (2002).
30. Zhang W., Segura B. J., Mulholland M. W., Peptides, 23, 1793-1801 (2002).
31. Miyoshi R., Kito S., Nomoto T., Neuropeptides, 18, 115-119 (1991).
32. Shinohara S., Kawasaki K., Neuroscience, 78, 1005-1016 (1997).
33. Xu T., Liu N. J., Li C. Q., Shangguan Y., Yu Y. X., Kang H. G., Han J. S., Brain Res., 730, 207-211 (1996).
34. Bayliss D. A., Umemiya M., Berger A. J., J. Physiol., 485, 635-647 (1995).
35. Cox C. L., Huguenard J. R., Prince D. A., J. Neurophysiol., 74, 990-1000 (1995).
36. Kombian S. B., Ananthalakshmi K. V., Parvathy S. S., Matowe W. C., J. Physiol., 555, 71-84 (2004).